Description

Slabilax (sodium picosulfate) oral drops 7.5 mg/ml. 30 ml. vial

Ingredients

Active ingredient: Each ml contains 7.5 mg of sodium picosulfate. Other ingredients include [list excipients].

Dosage

Adults: The usual dose is [dosage] once daily. Children: Dosage should be determined by a healthcare provider.

Indications

Slabilax oral drops are indicated for the treatment of constipation and to facilitate bowel movements.

Contraindications

Do not use Slabilax oral drops if:

• You are allergic to sodium picosulfate or any other ingredients in the product.
• You have severe dehydration.
• You have a bowel obstruction.

Directions

Shake the vial before use. Administer the drops orally. Follow the dosage instructions provided by your healthcare provider.

Scientific Evidence

Studies have shown that sodium picosulfate, the active ingredient in Slabilax oral drops, is effective in treating constipation by stimulating colonic peristalsis. Research by [Author, Year] demonstrated a significant improvement in bowel movement frequency and consistency compared to a placebo.

Additional Information

It is important to drink an adequate amount of fluids while using Slabilax to prevent dehydration. Consult your doctor if you experience severe abdominal pain or if constipation persists after using the product.

Pharmacological Effects: Sodium picosulfate is a stimulant laxative that acts directly on the colonic mucosa, inducing bowel movements by increasing the motility of the colon. It is metabolized into an active form in the colon, where it exerts its laxative effect.

Clinical Trials: Clinical trials have shown that Slabilax oral drops are well-tolerated and effective in providing relief from constipation. In a randomized controlled trial by [Researcher, Year], patients using sodium picosulfate experienced a significant improvement in stool frequency and consistency compared to the control group.